MLC901 (NeuroAiD)
Post‑stroke, Traumatic Brain Injury, Cognitive Decline
Phase 2/3Active
Key Facts
Indication
Post‑stroke, Traumatic Brain Injury, Cognitive Decline
Phase
Phase 2/3
Status
Active
Company
About Moleac
Moleac commercializes evidence‑based herbal medicines for stroke, TBI and neurodegeneration, with NeuroAiD already generating global sales.
View full company profile